Lijun Ma, MD, PhD

Research Interests

Education: MD, Nanjing Medical University - China, 1991; PhD, Nanjing Medical University - China, 1999
Residency: Internal Medicine, Nanjing University of Science and Technology Medical Center, 1994
Fellowship: Genetic Epidemiology, National Institutes of Health, 2004; Molecular Genetics, National Institutes of Health, 2009; Molecular Biology, Wake Forest University School of Medicine, 2011
Positions: Associate Professor, Nephrology
Departments and Affiliations: Nephrology

APOL1 and Mortality in Patients on Dialysis. Murea M, Ma L, Freedman BI. Cardiorenal Med. 2019; 9(4):261-264.
Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans. Guan M, Keaton JM, Dimitrov L, Hicks PJ, Xu J, Palmer ND, Ma L, Das SK, Chen YI, Coresh J, Fornage M, Franceschini N, Kramer H, Langefeld CD, Mychaleckyj JC, Parekh RS, Post WS, Rasmussen-Torvik LJ, Rich SS, Rotter JI, Sedor JR, Thornley-Brown D, Tin A, Wilson JG, Freedman BI, Bowden DW, Ng MCY. Hum Genomics. 2019 05; 13(1):21.
Mechanisms of Injury in APOL1-associated Kidney Disease. Ma L, Divers J, Freedman BI. Transplantation. 2019 03; 103(3):487-492.
JC polyoma viruria associates with protection from chronic kidney disease independently from apolipoprotein L1 genotype in African Americans. Freedman BI, Kistler AL, Skewes-Cox P, Ganem D, Spainhour M, Turner J, Divers J, Langefeld CD, Murea M, Hicks PJ, Hemal AK, Snipes JA, Zhao L, Abend JR, Lyles DS, Ma L, Skorecki KL. Nephrol. Dial. Transplant. 2018 11; 33(11):1960-1967.
APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD. Freedman BI, Limou S, Ma L, Kopp JB. Am. J. Kidney Dis. 2018 11; 72(5 Suppl 1):S8-S16.

View More Publications